Please click here to log in with you RCPsych web account details; you will be redirected back to CPD Online.If you have forgotten your College web account details, you will be able to reset them here.
Please click here to log in if your institution has a subscription to CPD Online with Athens access.
Please click here to log in if you are subscribed through Medicom Netherlands.
If you having troubles signing in with the options above, please try this alternative login route.
Module home
Module introduction Module information
Related articles: BJPsych Advances About the authors
Learning notes
Pre-module test
Section 1: Treatment options in opioid dependence
(1.1) Section 1: Treatment options in opioid dependence
(1.2) The size of the problem: UK
(1.3) The size of the problem: Scotland
(1.4) Interactive exercise: probability of infection
(1.5) Reflection
(1.6) The role of prescribing in opioid dependence
(1.7) NICE-approved interventions
(1.8) Interactive exercise: choice of treatment modality
(1.9) Section 1: Recap
(1.10) Section 1: Summary
Section 2: Understanding how buprenorphine works
(2.1) Section 2: Understanding how buprenorphine works
(2.2) Buprenorphine as a mixed agonist-antagonist opioid
(2.3) The pharmacology of buprenorphine – partial agonist at μ receptor
(2.4) Effect of illicit opioid use when taking buprenorphine
(2.5) How buprenorphine works
(2.6) Pharmacology of buprenorphine – other properties
(2.7) Dosing of buprenorphine
(2.8) Buprenorphine and naloxone preparations
(2.9) Advantages and disadvantages of buprenorphine treatment
(2.10) Pregnancy: a special case?
(2.11) Management of buprenorphine in pregnancy
(2.12) Reflection
(2.13) Reflection: pointers
(2.14) Section 2: Recap
(2.15) Section 2: Summary
Section 3: Buprenorphine prescribing, induction and titration
(3.1) Section 3: Buprenorphine prescribing, induction and titration
(3.2) Assessment
(3.3) Which opioid-dependent patients are likely to do well on buprenorphine?
(3.4) Which opioid-dependent patients are likely to do well on buprenorphine?
(3.5) Clinical vignette: Dave
(3.6) Reflection: suggested answers
(3.7) Getting someone started on buprenorphine
(3.8) Getting someone started on buprenorphine
(3.9) Giving the initial dose
(3.10) Inadequate dose or precipitated withdrawals
(3.11) Precipitated withdrawal
(3.12) Inadequate dose of buprenorphine
(3.13) Clinical vignette: Steven
(3.14) Suggested answers
(3.15) Section 3: Recap
(3.16) Section 3: Summary
Section 4: Maintaining treatment on buprenorphine
(4.1) Section 4: Maintaining treatment on buprenorphine
(4.2) Titration to optimal dose
(4.3) Maintaining a patient on buprenorphine
(4.4) Clinical vignette: Danielle
(4.5) Suggested answers
(4.6) Section 4: Recap
(4.7) Section 4: Summary
Section 5: Detoxification from opioids using buprenorphine
(5.1) Section 5: Detoxification from opioids using buprenorphine
(5.2) When to start a detoxification programme
(5.3) Interactive exercise: how to reduce and stop buprenorphine
(5.4) Example 1: brief buprenorphine detoxification regimen
(5.5) Example 2: standard 28-day buprenorphine detoxification regimen
(5.6) Relapse prevention
(5.7) Reviewing the patient's progress through treatment
(5.8) Section 5: Recap
(5.9) Section 5: Summary
Module summary
Module test
Acknowledgements
Send feedback
Useful resources
Take-home notes
References
Further reading